A hazardous link between malnutrition, inflammation and oxidative stress in renal patients

Clinical Biochemistry

Volumn 45, Issue 15, 2012, Pages 1202-1205

  Kotur Stevuljevic, Jelena ^a   Simic Ogrizovic, Sanja ^b   Dopsaj, Violeta ^a,b   Stefanovic, Aleksandra ^a   Vujovic, Ana ^a   Ivanic Corlomanovic, Tatjana ^c   Spasic, Slavica ^a   Kalimanovska Spasojevic, Vesna ^a   Jelic Ivanovic, Zorana ^a  

^a UNIVERSITY OF BELGRADE   (Serbia)

^b CLINICAL CENTER OF SERBIA   (Serbia)

^c Health Centre   (Serbia)

Author keywords

Inflammation; Malnutrition; Oxidative stress; Paraoxonase 1

Indexed keywords

ARYLDIALKYLPHOSPHATASE;

ADULT; ARTICLE; ATHEROSCLEROSIS; CARDIOVASCULAR RISK; CHRONIC KIDNEY DISEASE; COHORT ANALYSIS; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEATH; DISEASE ASSOCIATION; DISEASE COURSE; ENZYME ACTIVITY; FEMALE; HEMODIALYSIS PATIENT; HUMAN; INFLAMMATION; KAPLAN MEIER METHOD; LOG RANK TEST; MAJOR CLINICAL STUDY; MALE; MALNUTRITION; MORTALITY; OXIDATIVE STRESS; PRIORITY JOURNAL; STATISTICAL SIGNIFICANCE;

ADULT; ARYLDIALKYLPHOSPHATASE; CASE-CONTROL STUDIES; DYSLIPIDEMIAS; FEMALE; HUMANS; INFLAMMATION; KAPLAN-MEIER ESTIMATE; KIDNEY FAILURE, CHRONIC; MALE; MALNUTRITION; MIDDLE AGED; OXIDATIVE STRESS; PROSPECTIVE STUDIES; RENAL DIALYSIS;

EID: 84866305373     PISSN: 00099120     EISSN: 18732933     Source Type: Journal    
DOI: 10.1016/j.clinbiochem.2012.04.021     Document Type: Article

References (14)

1. Stenvinkel P., Pecoits-Filho R., Lindholm B. Coronary artery disease in end-stage renal disease: no longer a simple plumbing problem. J Am Soc Nephrol 2003, 14:1927-1939.
2. Pawlak K., Pawlak D., Mysliwiec M. Cu/Zn superoxide dismutase plasma levels as a new useful clinical biomarker of oxidative stress in patients with end-stage renal disease. Clin Biochem 2005, 38(8):700-705.
3. Prinsen B., de Sain-van der Velden M., de Koning E., Koomans H., Berger R., Rabelink T. Hypertriglyceridemia in patients with chronic renal failure: possible mechanisms. Kidney Int 2003, 63:121-124.
4. Aviram M., Rosenblat M., Bisgaier C.L., Newton R.S., Primo-Parmo S.L., La Du B.N. Paraoxonase inhibits high-density lipoprotein oxidation and preserves its functions. A possible peroxidative role for paraoxonase. J Clin Invest 1998, 101:1581-1590.
5. Richter R., Furlong C.E. Determination of paraoxonase (PON1) status requires more than genotyping. Pharmacogenetics 1999, 9:745-753.
6. Kotur-Stevuljevic J., Spasic S., Stefanovic A., Zeljkovic A., Bogavac-Stanojevic N., Kalimanovska-Ostric D., et al. Paraoxonase-1 (PON1) activity, but not PON1Q192R phenotype, is a predictor of coronary artery disease in a middle-aged Serbian population. Clin Chem Lab Med 2006, 44:1206-1213.
7. Stenvinkel P., Heimburger O., Paultre F., Diczfalusy U., Wang T., Berglund L., et al. Strong association between malnutrition, inflammation and atherosclerosis in chronic renal failure. Kidney Int 1999, 55:1899-1911.
8. Joki N., Hase H., Tanaka Y., Takahashi Y., Saijyo T., Ishikawa H., et al. Relationship between serum albumin level before initiating haemodialysis and angiographic severity of coronary atherosclerosis in end-stage renal disease patients. Nephrol Dial Transplant 2006, 21:1633-1639.
9. Pecoits-Filho R., Lindholm B., Stenvinkel P. The malnutrition, inflammation, and atherosclerosis (MIA) syndrome-the heart of the matter. Nephrol Dial Transplant 2002, 17:28-31.
10. Rashid S., Barrett H.R., Uffelman K.D., Watanabe T., Adeli K., Lewis G.F. Lipolytically modified triglyceride-enriched HDLs are rapidly cleared from the circulation. Arterioscler Thromb Vasc Biol 2002, 22:483-487.
11. Rosenblat M., Gaidukov L., Khersonsky O., Vaya J., Oren R., Tawfik D.S., et al. The catalytic histidine dyad of high density lipoprotein associated serum paraoxonase-1 (PON1) is essential for PON1-mediated inhibition of low density lipoprotein oxidation and stimulation of macrophage cholesterol efflux. J Biol Chem 2006, 281(11):7657-7665.
12. Durrington P.N., Mackness B., Mackness M. Paraoxonase and atherosclerosis. Arterioscler Thromb Vasc Biol 2001, 21:473-480.
13. Himmelfarb J. Oxidative stress in haemodialysis. Contrib Nephrol 2008, 161:132-137. Karger, Basel. C. Ronco, D.N. Cruz (Eds.).
14. Lahrach H., Ghalim N., Taki H., Kettani A., Er-Rachdi L., Ramdani B., et al. Serum paraoxonase activity, high-sensitivity CRP, and lipoprotein disturbances in end-stage renal disease patients on long-term haemodialysis. J Clin Lipidol 2008, 2:43-50.